Neuberger Berman Group’s Galectin Therapeutics Inc. - Warrants GALTW Stock Holding History

Neuberger Berman Group’s Portfolio GALTW Stock Details GALTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-125,919	Closed	-$7K	–	1703
2016 Q4	$7K	Hold	125,919	–	–	﹤0.01%	1583
2016 Q3	$20K	Buy	+125,919	New	+$44.3K	﹤0.01%	1579

Neuberger Berman Group's GALTW Position: Q1 2017 in Review

Neuberger Berman Group sold out of Galectin Therapeutics Inc. - Warrants (GALTW) in Q1 2017, closing a stake of 125,919 shares — an estimated $7K sold.

Neuberger Berman Group first reported a position in GALTW in Q3 2016 and held it in 2 quarters. The position peaked at $20K in Q3 2016. 0 funds tracked by Wall St. Rank hold GALTW as of Q1 2017.

Neuberger Berman Group reported no remaining Galectin Therapeutics Inc. - Warrants position as of Q1 2017 after selling out during the quarter.
Neuberger Berman Group sold 125,919 Galectin Therapeutics Inc. - Warrants shares in Q1 2017, an estimated $7K.
Neuberger Berman Group first reported a position in Galectin Therapeutics Inc. - Warrants in Q3 2016 and held it in 2 quarters.
Neuberger Berman Group's Galectin Therapeutics Inc. - Warrants position peaked at $20K in Q3 2016.
0 funds tracked by Wall St. Rank held Galectin Therapeutics Inc. - Warrants as of Q1 2017.

Based on Neuberger Berman Group's 13F filing for Q1 2017, filed 10 May 2017.